DOI: 10.1055/s-00035024

Thrombosis and Haemostasis

Issue 07 · Volume 80 · 1998 DOI: 10.1055/s-008-36003

Review Articles

1
Everse, Stephen J.; Spraggon, Glen; Doolittle, Russell F.: A Three-Dimensional Consideration of Variant Human Fibrinogens
10
Zacharski, Leo R.; Ornstein, Deborah L.: Heparin and Cancer
24
Bouma, Bonno N.; von dem Borne, Peter A. Kr.; Meijers, Joost C. M.: Factor XI and Protection of the Fibrin Clot against Lysis – a Role for the Intrinsic Pathway of Coagulation in Fibrinolysis

Rapid Communication

28
Kuwahara, Mitsuhiro; Sugimoto, Mitsuhiko; Tsuji, Shizuko; Miyata, Shigeki; Nishio, Kenji; Kaku, Seiji; Suzuki, Ken-ichi; Kawasaki, Tomihisa; Yoshioka, Akira: Comparative Studies on the Antiplatelet Effects of a Humanized Anti-Platelet Glycoprotein IIb/IIIa Antibody (YM337) and ReoPro under Flow Conditions
32
Bowen, D. J.; Standen, G. R.; Mazurier, C.; Gaucher, C.; Cumming, A.; Keeney, S.; Bidwell, J.: Type 2N von Willebrand Disease: Rapid Genetic Diagnosis of G2811A (R854Q), C2696T (R816W), T2701A (H817Q) and G2823T (C858F) – Detection of a Novel Candidate Type 2N Mutation: C2810T (R854W)
37
Romeuf, Christophe de; Mazurier, Claudine: Comparison between von Willebrand Factor (VWF) and VWF Antigen II in Normal Individuals and Patients with von Willebrand Disease
42
Jackson, Denise E.; White, Melanie M.; Jennings, Lisa K.; Newman, Peter J.: A Ser162→ Leu Mutation within Glycoprotein (GP) IIIa (Integrin β3) Results in an Unstable αIIbβ3 Complex that Retains Partial Function in a Novel Form of Type II Glanzmann Thrombasthenia
49
Leroyer, Christophe; Mercier, Bernard; Oger, Emmanuel; Chenu, Eric; Abgrall, Jean-François; Férec, Claude; Mottier, Dominique: Prevalence of 20210 A Allele of the Prothrombin Gene in Venous Thromboembolism Patients
52
Smulders, Ronald A.; Stehouwer, Coen D. A.; Schalkwijk, Casper G.; Donker, Ab J. M.; van Hinsbergh, Victor W. M.; TeKoppele, Johan M.: Distinct Associations of HbA1c and the Urinary Excretion of Pentosidine, an Advanced Glycosylation End-product, with Markers of Endothelial Function in Insulin-dependent Diabetes mellitus
58
Ferroni, P.; Speziale, G.; Ruvolo, G.; Giovannelli, A.; Pulcinelli, F. M.; Lenti, L.; Pignatelli, P.; Criniti, A.; Tonelli, E.; Marino, B.; Gazzaniga, P. P.: Platelet Activation and Cytokine Production during Hypothermic Cardiopulmonary Bypass – A Possible Correlation?
65
Downey, Colin; Kazmi, Rashid; Toh, Cheng Hock: Early Identification and Prognostic Implications in Disseminated Intravascular Coagulation through Transmittance Waveform Analysis
70
de Groot, Marco R.; Büller, Harry R.; ten Cate, Jan W.; Kooy, Marinus van Marwijk: Use of a Heparin Nomogram for Treatment of Patients with Venous Thromboembolism in a Community Hospital
74
Røjkjær, Rasmus; Hasan, Ahmed A. K.; Motta, Guacyara; Schousboe, Inger; Schmaier, Alvin H.: Factor XII Does not Initiate Prekallikrein Activation on Endothelial Cells
82
Mauron, Thomas; Lämmle, Bernhard; Wuillemin, Walter A.: Influence of Low Molecular Weight Heparin and Low Molecular Weight Dextran Sulfate on the Inhibition of Coagulation Factor XIa by Serpins
87
Liang, Zhong; Cooper, Adrian; DeFord, Melanie E.; Carmeliet, Peter; Collen, Desire; Castellino, Francis J.; Rosen, Elliot D.: Cloning and Characterization of a cDNA Encoding Murine Coagulation Factor X
92
Thorelli, Elisabeth; Kaufman, Randal J.; Dahlbäck, Björn: Cleavage Requirements of Factor V in Tissue-factor Induced Thrombin Generation
99
Robert, A.; Querrec, Le A.; Delahousse, B.; Caron, C.; Houbouyan, L.; Boutière, B.; Horellou, M.H.; Reber, G.; Sié, P.; the Groupe «Méthodologie en Hémostase» du Groupe d’Etudes sur l’Hémostase et la Thrombose: Control of Oral Anticoagulation in Patients with the Antiphospholipid Syndrome – Influence of the Lupus Anticoagulant on International Normalized Ratio
104
Toulon, Pierre; Boutière, Brigitte; Horellou, Marie-Hélène; Trzeciak, Marie Christine; Samama, Meyer M.: Monitoring Heparin Therapy Using Activated Partial Thromboplastin Time – Results of a Multicenter Trial Establishing the Therapeutic Range for SILIMAT, a Reagent with High Sensitivity to Heparin
109
Girard, Pascal; Nony, Patrice; Erhardtsen, Elisabeth; Delair, Sylvie; Ffrench, Patrick; Dechavanne, Marc; Boissel, Jean-Pierre: Population Pharmacokinetics of Recombinant Factor VIIa in Volunteers Anticoagulated with Acenocoumarol
114
DeLa Cadena, Raul A.; Majluf-Cruz, Abraham; Stadnicki, Antoni; Tropea, Margaret; Reda, Debra; Agosti, Jan M.; Colman, Robert W.; Suffredini, Anthony F.: Recombinant Tumor Necrosis Factor Receptor p75 Fusion Protein (TNFR:Fc) Alters Endotoxin-Induced Activation of the Kinin, Fibrinolytic, and Coagulation Systems in Normal Humans
119
Chu, Michael; Bird, Catherina H.; Teasdale, Melvena; Bird, Phillip I.: Turnover of Thrombomodulin at the Cell Surface Occurs at a Similar Rate to Receptors that Are Not Actively Internalized
128
Cain, Dean; Hutson, Susan M.; Wallin, Reidar: Warfarin Resistance Is Associated with a Protein Component of the Vitamin K 2,3-Epoxide Reductase Enzyme Complex in Rat Liver
134
Sakkinen, Pamela A.; Cushman, Mary; Psaty, Bruce M.; Kuller, Lewis H.; Bajaj, S. Paul; Sabharwal, Arun K.; Boineau, Robin; Macy, Elizabeth; Tracy, Russell P.: Correlates of Antithrombin, Protein C, Protein S, and TFPI in a Healthy Elderly Cohort
140
Okada, S. Steve; Golden, Michael A.; Raghunath, P. N.; Tomaszewski, John E.; David, Mary L.; Kuo, Alice; Kariko, Katalin; Barnathan, Elliot S.: Native Atherosclerosis and Vein Graft Arterialization: Association with Increased Urokinase Receptor Expression In Vitro and In Vivo
148
Fowler, Bruce; Mackman, Nigel; Parmer, Robert J.; Miles, Lindsey A.: Binding of Human Single Chain Urokinase to Chinese Hamster Ovary Cells and Cloning of Hamster u-PAR
155
Chudzinski-Tavassi, Ana Marisa; Kelen, Eva Maria A.; Rosa, Ana Paula de Paula; Loyau, Stephane; Sampaio, Claudio A. M.; Bon, Cassian; Anglés-Cano, Eduardo: Fibrino(geno)lytic Properties of Purified Hementerin, a Metalloproteinase from the Leech Haementeria depressa
161
Urano, Tetsumei; Nagai, Nobuo; Matsuura, Megumi; Ihara, Hayato; Takada, Yumiko; Takada, Akikazu: Human Thrombin and Calcium Bound Factor Xa Significantly Shorten tPA-Induced Fibrin Clot Lysis Time via Neutralization of Plasminogen Activator Inhibitor Type 1 Activity
167
Biasiutti, F. Demarmels; Sulzer, I.; Stucki, B.; Wuillemin, W. A.; Furlan, M.; Lämmle, B.: Is Plasminogen Deficiency a Thrombotic Risk Factor ? – A Study on 23 Thrombophilic Patients and their Family Members
171
Wartiovaara, Ulla; Salven, Petri; Mikkola, Hanna; Lassila, Riitta; Kaukonen, Jaakko; Joukov, Vladimir; Orpana, Arto; Ristimäki, Ari; Heikinheimo, Markku; Joensuu, Heikki; Alitalo, Kari; Palotie, Aarno: Peripheral Blood Platelets Express VEGF-C and VEGF which Are Released during Platelet Activation
176
Callan, Mary Beth; Shofer, Frances S.; Wojenski, Carol; Giger, Urs: Chrono-lume® and Magnesium Potentiate Aggregation of Canine but not Human Platelets in Citrated Platelet-Rich Plasma
181
Tamai, Yoshiko; Takami, Hideki; Nakahata, Rieko; Nakui, Yuka; Akagi, Tomoaki; Munakata, Akihiro: Development and Practical Use of the New Quantitative Bleeding Time Test Apparatus
186
Deschênes, Isabelle; Finkle, Carolyn D.; Winocour, Peter D.: Effective Use of BCH-2763, a New Potent Injectable Direct Thrombin Inhibitor, in Combination with Tissue Plasminogen Activator (tPA) in a Rat Arterial Thrombolysis Model
192
Dickneite, Gerhard; Nicolay, Uwe; Friesen, Heinz-Jürgen; Reers, Martin: Development of an Anti-Bleeding Agent for Recombinant Hirudin Induced Skin Bleeding in the Pig

Letters to the Editor

199
Lethagen, S.; Frick, K.; Isaksson, C.; Kristoffersson, A.-C.; Holmberg, L.: Revised Classification and Treatment of von Willebrand Disease
200
Morita, Hiroyuki; Kurihara, Hiroki; Taguchi, Jun-ichi; Ohno, Minoru; Yazaki, Yoshio: ACE and MTHFR Gene Polymorphisms: Genetic Coronary Risk Factors Relating to Different Aspects of Pathophysiology
201
Veyradier, Agnès; Wolf, Martine; Boyer-Neumann, Catherine; Parent, Florence; Simonneau, Gérald; Meyer, Dominique: Recurrent Thromboembolism in Two Unrelated Patients with Double Heterozygosity for Factor V R506Q and Factor II 20210G/A Mutations
202
Bertolaccini, M. L.; Atsumi, T.; Hunt, B. J.; Amengual, O.; Khamashta, M. A.; Hughes, G. R. V.: Prothrombin Mutation Is not Associated with Thrombosis in Patients with Antiphospholipid Syndrome
203
Shibata, Yuhki; Hashimoto, Hisakuni; Kurata, Chinori; Ohno, Ryuzo; Kazui, Teruhisa; Takinami, Makoto: Influence of Physical Activity on Warfarin Therapy
204
Meijer, K.; Sieders, E.; Slooff, M. J. H.; de Wolf, J. Th. M.; van der Meer, J.: Effective Treatment of Severe Bleeding due to Acquired Thrombocytopathia by Single Dose Administration of Activated Recombinant Factor VII
206
Girolami, Antonio: Idiopathic Versus Secondary Thrombosis as a Predictive Marker of Occult Malignancy
207
Weber, Artur-Aron; Schrör, Karsten: Complex Control of Vascular Smooth Muscle Cell Growth by Thromboxane A2
208
Karmochkine, Marina; Ankri, Annick; Calvez, Vincent; Bonmarchant, Manuela; Coutellier, Anne; Herson, Serge: Plasma Hypercoagulability Is Correlated to Plasma HIV Load*
209
Grant, Peter J.: Metformin Reduces Circulating Factor VII Concentrations in Patients with Type 2 Diabetes mellitus